Back to User profile » Dr Susan Guba
Paper published by Dr Susan Guba:
Review
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, Slapak CA, Lahn MM
Drug Design, Development and Therapy 2015, 9:4479-4499
Published Date: 10 August 2015